Publications by authors named "Fatemeh Karimi Madab"

Background: Sitagliptin is an antidiabetic drug that inhibits dipeptidyl peptidase-4 enzyme. This study aimed to investigate the antinociceptive and anti-inflammatory effects of sitagliptin in formalin and carrageenan tests and determine the possible mechanism(s) of its antinociceptive activity.

Methods: Male Swiss mice (25-30 g) and male Wistar rats (180-220 g) were used for formalin and carrageenan tests, respectively.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Fatemeh Karimi Madab"

  • - Fatemeh Karimi Madab's recent research focuses on the pharmacological effects of sitagliptin, an antidiabetic medication, particularly its anti-inflammatory and antinociceptive properties in animal models.
  • - The study employs both formalin and carrageenan tests using male Swiss mice and male Wistar rats to assess the drug's effects on pain and inflammation.
  • - Findings suggest that sitagliptin may possess significant antinociceptive activity, shedding light on possible mechanisms involved that could contribute to its therapeutic applications beyond diabetes management.